Jean Edouard Desmedt was affiliated with the Université Libre de Bruxelles in Belgium. Their research contributions were primarily in the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine.
Their work spanned several subfields, including Cancer Research, Molecular Biology, and Immunology and Allergy. The main topics they explored involved NF-κB Signaling Pathways, Melanoma and MAPK Pathways, and Cell Adhesion Molecules Research.
Desmedt's research appeared in scholarly venues, with publications notably in EJC Skin Cancer.
Their recent paper was titled Serum levels of TWEAK are prognostic for disease recurrence in stage I-III melanoma, published in 2025 in EJC Skin Cancer.
The scientist frequently collaborated with these co-authors on their research projects.
Jean Edouard Desmedt;Guy Chéron
Jean Edouard Desmedt;Guy Chéron
François F. Mauguière;Jean Edouard Desmedt;Jean Hubert J. Courjon
Jean Edouard Desmedt;Claude Tomberg
Jean Edouard Desmedt;Marc Bourguet
Jean Edouard Desmedt;Guy Chéron
Jean Edouard Desmedt;Tran Huy Nguyen;Marc Bourguet
Jean Edouard Desmedt;Claude Tomberg
Jean Edouard Desmedt;Julien Debecker
Jean Edouard Desmedt;Donald Robertson
Jean Edouard Desmedt;Guy Chéron
Jean Edouard Desmedt;Nguyen Tran Huy;Marc Bourguet
Jean Edouard Desmedt
François Mauguière;Jean Edouard Desmedt;Jean Hubert J. Courjon
Marc R. Nuwer;Michael Aminoff;John Desmedt;Andrew A. Eisen
Jean Edouard Desmedt;Eric Brunko;Julien Debecker
Jean Edouard Desmedt;Guy Chéron
Pierre Raoul Noel;Jean Edouard Desmedt
Jean Edouard Desmedt
Jean Edouard Desmedt
If you think any of the details on this page are incorrect, let us know.